Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG.
| Image |  |
|---|---|
| Description | scientific article published on 14 February 2012 |
| Author/s | |
| Publication date | February 14, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |